Showing results (781-790 of 994) with videos related to

Sort By:
Pageof 100
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 22, 2017
Targeted inactivation of copper transporter Atp7b in hepatocytes causes liver steatosis and obesity in miceAbigael Muchenditsi, Haojun Yang, James P Hamilton, et al.
Water Research|October 13, 2024
Evaluating the suitability of large-scale datasets to estimate nitrogen loads and yields across different spatial scalesAndrés Felipe Suárez-Castro, Dale M Robertson, Bernhard Lehner, et al.
G3 (Bethesda, Md.)|November 17, 2016
Analysis of Ribosome-Associated mRNAs in Rice Reveals the Importance of Transcript Size and GC Content in TranslationDongyan Zhao, John P Hamilton, Michael Hardigan, et al.
Plos One|October 4, 2007
Novel decapeptides that bind avidly and deliver radioisotope to colon cancer cellsJohn M Abraham, Fumiaki Sato, Yulan Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progressionJames P Hamilton, Fumiaki Sato, Zhe Jin, et al.
The Plant Journal : for Cell and Molecular Biology|March 12, 2015
Genome-guided investigation of plant natural product biosynthesisFranziska Kellner, Jeongwoon Kim, Bernardo J Clavijo, et al.
Hepatology (Baltimore, Md.)|December 19, 2015
Activation of liver X receptor/retinoid X receptor pathway ameliorates liver disease in Atp7B(-/-) (Wilson disease) miceJames P Hamilton, Lahari Koganti, Abigael Muchenditsi, et al.
Plos One|June 26, 2008
Generation of small 32P-labeled peptides as a potential approach to colorectal cancer therapyJohn M Abraham, Yulan Cheng, James P Hamilton, et al.
Future Oncology (London, England)|July 29, 2024
VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+/HER2- advanced breast cancerErika P Hamilton, Cynthia Ma, Michelino De Laurentiis, et al.
Scientific Reports|November 7, 2025
A fixation-compatible protocol for intracellular and surface marker-based detection of circulating tumor cells in hepatocellular carcinomaBoqun Zhu, Kanako Yoshida, Harry Luu, et al.
Pageof 100